Fibroblast Reprogramming With mod-mRNA and microRNA Without Feeder Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for reprogramming differentiated somatic cells into induced pluripotent stem cells (iPSCs) face challenges such as low efficiency, reliance on feeder cells, integration risks, high costs, and inconsistent results with primary human fibroblast cells, particularly when using modified mRNA (mod-mRNA) approaches.
Innovation Solution
A feeder-free and integration-free method utilizing modified mRNA (mod-mRNA) in combination with microRNA mimics (m-miRNAs) for reprogramming primary human fibroblast cells at low densities, including seeding as few as a single cell, to achieve high reprogramming efficiency and generate clinically relevant iPSC lines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If feeder cells are used in reprogramming, then cell survival and reprogramming efficiency are improved, but contamination risks and process complexity increase
Solution Approach 1:
The invention extracts and eliminates the feeder cell component from the reprogramming system. By developing a feeder-free culture system with optimized medium formulations and growth factors, the method achieves high reprogramming efficiency without requiring feeder cells, thereby eliminating contamination risks associated with feeder cell maintenance and use.
Solution Approach 2:
The invention introduces intermediary substances such as growth factors, cytokines, and extracellular matrix components as mediators to replace the functional role of feeder cells. These intermediaries provide necessary survival signals and differentiation cues without the contamination risks of live feeder cells.
2Productivity
If viral vectors are used for factor delivery, then reprogramming efficiency is improved, but genomic integration risks increase
Solution Approach 1:
The invention extracts and removes the viral vector component from the reprogramming system. By using non-integrating delivery methods such as episomal vectors, mRNA transfection, or protein transduction, the method achieves high reprogramming efficiency without genomic integration, eliminating the associated safety risks.
Solution Approach 2:
The invention employs transient, non-integrating delivery vehicles such as mRNA or protein that are naturally degraded after delivering their function. These disposable delivery methods provide high reprogramming efficiency without persistent genomic presence, eliminating long-term integration risks.
3Productivity
If high cell density is used during reprogramming, then reprogramming efficiency is improved, but resource consumption and cost increase
Solution Approach 1:
The invention optimizes the cell density parameter to achieve an optimal balance between reprogramming efficiency and resource consumption. By conducting systematic parameter optimization, the method identifies the minimum effective cell density that maintains high reprogramming efficiency while minimizing medium, reagent, and space requirements.
Solution Approach 2:
The invention uses partial action by applying reprogramming factors and culture conditions only where and when needed, rather than uniformly across all cells. This targeted approach maintains high efficiency in reprogramming while reducing overall resource consumption through localized optimization.
Data Source
AI summary
The present disclosure relates to methods and compositions for reprogramming cells to a pluripotent state. In particular, it relates to an integration- and feeder cell-free method for reprogramming primary human fibroblast cells to induced pluripotent stem cells (iPSCs).